Detalles de la búsqueda
1.
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial.
Ann Hematol
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38842566
2.
IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis.
Blood
; 137(7): 945-958, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33254233
3.
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China.
BMC Cancer
; 23(1): 930, 2023 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37784037
4.
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling.
J Nanobiotechnology
; 21(1): 45, 2023 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755314
5.
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Age Ageing
; 51(1)2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34673897
6.
Treatment options for older unfit patients with acute myeloid leukemia.
Future Oncol
; 17(7): 837-851, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33522289
7.
MEG3 modulates TIGIT expression and CD4 + T cell activation through absorbing miR-23a.
Mol Cell Biochem
; 454(1-2): 67-76, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30382432
8.
A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study.
Am J Hematol
; 99(6): 1177-1179, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482543
9.
Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution.
Ann Diagn Pathol
; 34: 60-65, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29661730
10.
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
Hematol Oncol
; 35(4): 619-629, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27723108
11.
A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45α mRNA stability.
J Biol Chem
; 290(8): 4784-4800, 2015 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25561743
12.
Increased expression of TIGIT on CD4+ T cells ameliorates immune-mediated bone marrow failure of aplastic anemia.
J Cell Biochem
; 115(11): 1918-27, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24905442
13.
Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression.
Acta Haematol
; 132(2): 177-86, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603438
14.
The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability.
J Biol Chem
; 287(41): 34361-71, 2012 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22910906
15.
[Efficacy and Safety of Venetoclax-Based Induction Therapy in Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(4): 960-966, 2023.
Artículo
en Zh
| MEDLINE | ID: mdl-37551462
16.
A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis.
Front Oncol
; 13: 1104425, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37056341
17.
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Lancet Reg Health West Pac
; 34: 100720, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283978
18.
Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities.
Front Oncol
; 12: 805702, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372057
19.
[Clinical Characteristics and Prognosis of Systemic Anaplastic Large Cell Lymphoma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 30(4): 1109-1115, 2022 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-35981369
20.
Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens.
Front Oncol
; 12: 938550, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185185